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Introduction
Foot-and-mouth disease (FMD) is a highly contagious viral 
disease of cloven-hoofed animals including domestic rumi-
nants, pigs, and more than 70 wild animal species.1,21 Foot-
and-mouth disease virus (FMDV; order Picornavirales, 
family Picornaviridae, genus Aphthovirus) contains 7 sero-
types, namely O, A, C, Asia1, Southern African Territories 
(SAT)1, SAT2, and SAT3, all with a number of subtypes. 
Infection with 1 serotype does not prevent infection with 
other serotypes.8 Different serotypes have distinct geograph-
ical distributions and epidemiology; however, they are clini-
cally indistinguishable.22
The epidemiology of FMD in East Africa is complex with 
5 (O, A, SAT1, SAT2, and SAT3) out of the 7 serotypes being 
continuously present.22 Serotype C was last diagnosed in 
Kenya in 200418 while serotype Asia1 has never been diag-
nosed on the African continent.22
Previously, serological diagnosis of FMDV implied run-
ning up to 7 different tests for antibodies against each of the 
relevant serotypes; however, more broadly directed antibody 
tests detecting antibodies against all 7 serotypes of FMDV 
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Abstract. Diagnosis and control of Foot-and-mouth disease virus (FMDV) requires rapid and sensitive diagnostic tests. 
Two antibody enzyme-linked immunosorbent assay (ELISA) kits, Ceditest® FMDV-NS for the detection of antibodies against 
the nonstructural proteins of all FMDV serotypes and Ceditest® FMDV type O for the detection of antibodies against serotype O, were 
evaluated under African endemic conditions where the presence of multiple serotypes and the use of nonpurified vaccines 
complicate serological diagnosis. Serum samples from 218 African buffalo, 758 cattle, 304 goats, and 88 sheep were tested 
using both kits, and selected samples were tested not only in serotype-specific ELISAs for antibodies against primarily FMDV 
serotype O, but also against other serotypes. The FMDV-NS assay detected far more positive samples (93%) than the FMDV 
type O assay (30%) in buffalo (P < 0.05), with predominant antibodies against the South African Territories (SAT) serotypes, 
while the seroprevalence was generally comparable in cattle with antibodies against serotype O elicited by infection and/or 
vaccination. However, some districts had higher seroprevalence using the FMDV type O assay indicating vaccination without 
infection, while 1 cattle herd with antibodies against the SAT serotypes had far more positive samples (85%) using the FMDV-
NS versus the FMDV type O (10%), consistent with the latter test’s lower sensitivity for antibodies against SAT serotypes. 
Based on the current investigation, the FMDV type O ELISA may be limited by the presence of SAT serotypes. The FMD 
NS assay worked well as a screening test for antibodies against all FMDV serotypes present in Uganda; however, as long as 
nonpurified vaccines are applied in the region, this test cannot be used to differentiate between vaccinated and infected animals.
Key words: Ceditest® FMDV-NS; Ceditest® FMDV type O; Foot-and-mouth disease; Uganda.
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have recently been offered by a number of commercial com-
panies, including an enzyme-linked immunosorbent assay 
(ELISA) kit for detection of antibodies against all 7 sero-
types of FMDV marketed by Prionics AG, Switzerland: the 
Ceditest® FMDV-NSa (hereafter, NSP test). The same com-
pany has marketed a screening test for detection of antibod-
ies against serotype O, the Ceditest® FMDV type O ELISA 
kitb (hereafter, SP-O test), which has such broad specificities 
for antibodies against the Eurasian serotypes of FMDV (O, 
A, C, and Asia1)9 that it has been speculated that this test 
could work as a pan-FMDV antibody test.
The NSP test is a blocking ELISA that detects antibodies 
against the nonstructural 3ABC protein of FMDV in infected 
animals, independent of the serotype that induced the anti-
bodies.19 Like other commercially available test kits for anti-
bodies against the nonstructural proteins (NSPs) of FMDV, 
the NSP assay has important applications in differentiating 
infected from vaccinated animals.19 Conversely, the SP-O 
assay is based on the structural proteins (SPs) of FMDV 
serotype O and can be used in cattle, sheep, pigs, and goats.9 
These 2 test kits have been successfully used for investigat-
ing FMD outbreaks and for control programs.9,16,17
The NSP ELISAs are widely applied in the diagnosis of 
FMD and have been evaluated in Europe5 and to a lesser 
extent in Africa.6,7 In a direct comparison of 6 NSP ELISAs, 
the NSP test had comparative sensitivities of 98.9% and 
96.6% in field sera from Israel and Zimbabwe, respectively, 
while diagnostic specificity was 97.2% in nonvaccinated ani-
mals and 99.5% in experimental animals that had received 
1 vaccination.5 In Africa, using Hui–Walter latent class mod-
eling and comparing with a combination of neutralization test 
results for all 3 SAT serotypes of FMDV, it has been demon-
strated that the NSP test is a useful tool for screening buffalo 
infected with multiple SAT serotypes of FMDV with esti-
mated sensitivity of 87.7% and specificity of 87.3%.6 Using 
the same modeling methodology but without comparing to 
neutralization test results, estimated sensitivity and specific-
ity of 96.6% and 90.9%, respectively, have been found in 
Zebu cattle kept under extensive rangeland conditions in 
Cameroon.7 Although only limited studies of performance of 
these tests have been carried out among sheep and goats, 
lower sensitivity has been reported particularly in sheep.13
The SP-O test has mainly been used and evaluated in 
Europe and has been found to identify antibodies against 
serotypes O, A, C, and Asia1 in cattle, with higher sensitivity 
for antibodies against serotype O.9 The aim of the present 
study was to evaluate the performance of the SP-O and NSP 
tests in Ugandan cattle, sheep, goats, and African buffalo 
(Syncerus caffer). In addition, the SP-O test was compared to 
a solid phase blocking ELISA (SPBE) for detection of anti-
bodies against FMDV serotype O.4
Materials and methods
Serum samples were collected from Ugandan African 
buffalo, cattle, goats, and sheep. Two hundred eighteen 
samples from African buffalo were collected from Lake 
Mburo, Kidepo Valley, Murchison Falls, and Queen Elizabeth 
National Parks as described elsewhere.2,3 In addition, 449 
cattle sera were collected in July 2006 during an extensive 
postoutbreak (PO) sampling in a number of districts in the 
western and southwestern regions of Uganda and 309 sera 
were collected during an attempted random sampling (RS) 
within Kasese and Bushenyi Districts in 2007.14,15 Three 
hundred four goat sera and 88 sheep sera were collected 
from the same farms or villages during these sampling trips.4
Testing for antibodies against FMDV was done using the 
NSPa and SP-Ob tests according to the manufacturer’s 
instructions. Optical density values (OD) were determined 
using a dual wavelength ELISA readerc at 620 nm and 450 
nm. Results were expressed as OD% (ODP: ODsample in per-
cent of ODnegative controls),4 and cutoffs were set at 50%.
Selected samples, mostly positive for antibodies against 
NSPs, were screened at dilution 1:5 using an in-house SPBE 
for antibodies against FMDV serotype O (SPBE-O) with a 
cutoff of 50% as previously described.4 The selected samples 
included 174 buffalo sera, 126 cattle sera from the 2006 PO 
sampling, and 81 cattle sera from the 2007 RS sampling. The 
selected cattle sera constituted 28–80% of sera from each of 
the 18 herds with a history of recent clinical signs of FMD in 
2006 and 17–100% of sera from 16 randomly sampled farms 
without clinical signs of FMD in 2007. For small ruminants, 
all samples positive in the NSP test and/or the SP-O test from 
both 2006 and 2007 were further tested using the SPBE-O. In 
addition, 20 sera from 1 herd (Ks12)15 were examined in 
SPBEs for antibodies against all 7 serotypes of FMDV as pre-
viously described.4 Differences between groups were tested 
for statistical significance using chi-square, and differences 
between seroprevalence obtained with the NSP and SP-O tests 
were analyzed using McNemar test in a spreadsheet program.d
Results
Antibodies against NSPs, and SPs of FMDV serotype O, 
were detected in African buffalo, cattle, goat, and sheep sam-
ples (Table 1). Seroprevalence of antibodies against NSP 
was much higher in African buffalo (93%) compared to cat-
tle (48%), sheep (28%), and goats (9%), while cattle had the 
highest number of positives in the SP-O test (52%) compared 
to buffalo (30%) sheep (24%), and goats (7%).
In buffalo, for both tests, there was no significant differ-
ence in the seroprevalence of FMDV antibodies between 
national parks (P = 0.758 and P = 0.413 for the NSP and 
SP-O tests, respectively). Thus, the data from all buffalo 
samples were pooled, and statistical analysis of these results 
confirmed that the NSP test detected significantly more sero-
positive buffalo than the SP-O test (P < 0.005) in all the 4 
investigated national parks.
The results were less clear in cattle because the NSP test 
detected significantly more positive samples than did the 
SP-O test in samples from the 2007 RS, while it detected 
significantly fewer samples than did the SP-O test in the 2006 
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PO sampling (P < 0.001 for both comparisons). The differ-
ence in 2007 was caused by more positive samples in the 
NSP test than in the SP-O test in the Kasese District (P < 
0.001), while in 2006, it was caused by more positive sam-
ples in the SP-O test than in the NSP test in Mbarara (P = 
0.013) and Kiruhura (P < 0.001) districts. Moreover, the 2 
tests had different outcomes for approximately 20% of the 
samples from Kasese District in 2006, but this difference 
was not statistically significant since the samples that were 
only positive in one of the tests were distributed equally 
Table 1. Comparative evaluation of Ceditest® FMDV-NS (NSP) and Ceditest® FMDV type O (SP-O) enzyme-linked immunosorbent 
assay for the detection of antibodies against nonstructural and structural proteins of Foot-and-mouth disease virus in livestock and wildlife 
species in various districts and national parks in Uganda.
Samples/Origin Total NSP+ SP-O+ NSP+/SP-O+ NSP+/SP-O– NSP–/SP-O+ NSP–/SP-O–
Buffalo
2001–2008
 MFNP 53 51 (96) 19 (36) 18 33 1 1
 LMNP 18 17 (94) 6 (33) 6 11 0 1
 KVNP 39 36 (92) 14 (36) 13 23 1 2
 QENP 108 99 (92) 27 (25) 27 72 0 9
Total 218 203 (93) 66 (30) 64 139 2 13
Cattle
PO, 2006
 Bushenyi 59 28 (48) 30 (51) 28 0 2 29
 Isingiro 11 8 (73) 11 (91) 7 1 3 0
 Kasese 203 142 (70) 142 (70) 122 21 20 40
 Mbarara 51 36 (71) 48 (94) 35 1 13 2
 Mpigi 23 18 (78) 21 (91) 17 1 4 1
 Kiruhura 87 7 (8) 50 (58) 6 1 44 36
 Kampala 15 1 (7) 4 (27) 0 1 4 10
 Subtotal 449 240 (53) 306 (68) 215 26 90 118
RS, 2007
 Kasese 193 118 (61) 83 (43) 83 35 0 75
 Bushenyi 116 4 (4) 5 (4) 0 5 4 107
 Subtotal 309 122 (39) 88 (29) 83 40 5 181
Total 758 362 (48) 394 (52) 298 66 95 299
Goats
PO, 2006
 Kasese 9 3 (33) 6 (67) 3 0 3 3
 Bushenyi 15 0 (0) 0 (0) 0 0 0 15
 Mbarara 4 4 (100) 4 (100) 4 0 0 0
 Isingiro 5 0 (0) 0 (0) 0 0 0 5
 Subtotal 33 7 (21) 10 (30) 7 0 3 23
RS, 2007
 Kasese 143 20 (14) 9 (6) 4 16 2 121
 Bushenyi 128 0 (0) 1 (1) 0 1 3 124
 Subtotal 271 20 (7) 10 (4) 4 17 5 245
Total 304 27 (9) 20 (7) 11 17 8 268
Sheep
PO, 2006
 Kasese 13 13 (100) 13 (100) 13 0 0 0
 Subtotal 13 13 (100) 13 (100) 13 0 0 0
RS, 2007
 Kasese 57 12 (21) 8 (14) 6 6 2 43
 Bushenyi 18 0 (0) 0 (0) 0 0 0 18
 Subtotal 75 12 (16) 8 (11) 6 6 2 61
Total 88 25 (28) 21 (24) 19 6 2 61
*+ = positive; – = negative; PO = postoutbreak sampling; RS = random sampling; MFNP: Murchison Falls National Park; LMNP: Lake Mburo National 
Park; KVNP: Kidepo Valley National Park; QENP: Queen Elizabeth National Park. Numbers in parentheses are percentages.
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between the 2 tests (and thus not significantly different, P = 
0.859). The remaining district samples (Bushenyi, Isingiro, 
Mpigi, and Kampala in 2006, and Bushenyi in 2007) had 
comparable results with only a few samples differing 
between the 2 tests.
With regard to sera from goats and sheep, the differences 
between the results obtained with the 2 tests were either 
inconclusive or insignificant apart from those of goats in 
2007 where the NSP test found more positive animals than 
did the SP-O test (P = 0.0105).
When comparing the results obtained in dilution 1:5 in the 
SPBE-O test to results in the SP-O test, there was generally 
good agreement between the results obtained with the 2 tests 
in cattle, sheep, and goats in the 2006 PO sampling, while the 
results were more scattered in the 2007 RS and in buffalo, 
where the SPBE-O screening ELISA identified more positive 
cattle and buffalo samples than did the SP-O test (Table 2).
In the 2006 PO sampling, on-farm seroprevalence in the 
NSP and SP-O tests were generally comparable14; however, 
1 out of 22 cattle herds (Ks12) with a history of recent clini-
cal signs of FMD had much higher prevalence of antibodies 
against FMDV in the NSP test than in the SP-O test.14 
Analysis of serotype-specificity of FMDV antibodies of 20 
heads of cattle from this herd using SPBEs for all 7 serotypes 
revealed that these cattle exclusively had antibodies against 
the SAT serotypes (Table 3). Most of these 20 samples had 
low antibody titers against serotypes SAT2 and SAT3; how-
ever, 1 animal had a titer of 80 for antibodies against SAT2, 
3 animals had titers of 80–160 against SAT3, and 1 animal 
had a titer of 640 against SAT1. This herd was regularly 
grazed in Queen Elizabeth National Park.
Discussion
Interpretation of the higher seroprevalence of antibodies 
against NSPs than against SPs of FMDV serotype O in the 
investigated buffalo sera should take into consideration that 
when titrated, these sera had higher seroprevalences of anti-
bodies against the FMDV SAT serotypes than against sero-
type O.2,3 Thus, these data suggest that the SP-O test may be 
much less sensitive for antibodies against the SAT serotypes 
of FMDV circulating in Uganda than the NSP test. It may be 
speculated that the low sensitivity of the SP-O test in buffalo 
could be species-related; however, this test is a blocking 
ELISA, which is generally not species-specific. Moreover, 
the similar finding in a cattle herd (Ks12) of much higher 
seroprevalence in the NSP test and in the SPBEs for antibod-
ies against the SAT serotypes than in both the SP-O and 
SPBE-O tests supports that the low sensitivity in buffalo was 
not species-related.
In cattle, the high seroprevalence in both tests in most 
districts in 2006 were found during a major outbreak of 
FMDV serotype O in the region in 2006, which was pre-
ceded and followed by vaccination campaigns with nonpuri-
fied trivalent vaccines containing FMDV serotypes O, SAT1, 
and SAT2. Moreover, the majority of the sampled herds 
exhibited clinical evidence of exposure to FMDV and/or 
reported previous vaccination, and a serotype O virus was 
isolated from 2 probang samples collected from this out-
break.15 In agreement with this, all herds with clinical evi-
dence of FMDV infection, except the 1 Kasese herd described 
in Table 3 (Ks12), had high seroprevalence in the SP-O test 
and had high titers of antibodies against serotype O in the 
SPBE-O ELISA.15 The higher seroprevalence registered 
with the SP-O test in Mbarara, Kiruhura, and Kampala dis-
tricts is consistent with vaccinated animals that have not 
recently been infected.
The Kasese herd (Ks12; Table 3) with much higher sero-
prevalence in the NSP test (85%) than in the SP-O test (10%) 
had serological evidence of exposure to SAT serotypes, 
while all tested samples were negative in the SPBE-O 
ELISA. Thus, this result supports the preceding conclusion 
Table 2. Comparative screening results for Foot-and-mouth disease virus using the Ceditest® FMDV type O (SP-O) enzyme-linked 
immunosorbent assay (ELISA) and the solid phase blocking ELISA (SPBE-O) in buffalo, cattle, and small ruminants in Uganda.
Results of the SP-O/SPBE-O ELISAs
Species Total NSP positive +/+ +/– –/+ –/–
Buffalo 174 169 47 6 79 42
Postoutbreak sampling, 2006
Cattle 126 120 106 2 0 18
Goats 10 7 7 3 0* 0*
Sheep 13 13 13 0 0* 0*
Random sampling, 2007
Cattle 81 76 50 1 16 14
Goats 26 21 5 4 4 13
Sheep 14 12 7 1 2 4
*NSP = Ceditest® FMDV-NS (Cedi Diagnostics B.V., Leystad, The Netherlands [currently produced and marketed as Priocheck® FMDV-NS by Prionics 
AG, Schlieren-Zurich, Switzerland]. + = positive; – = negative. The samples investigated by SPBE-O were all SP-O positive.
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from the buffalo data that the SP-O test is a less suitable tool 
for screening antibodies against FMDV than the NSP test 
when antibodies against the Ugandan SAT serotypes of 
FMDV are prevailing.
The 2007 RS differed from the 2006 PO sampling in that 
the 2 districts under study had very different levels of sero-
prevalence in both the NSP and SP-O tests. Moreover, 
Bushenyi District had very low seroprevalence and had, 
except for a small, quickly contained outbreak in 2006 (sam-
pled in the 2006 PO sampling), been free from FMD for a 
prolonged time,14 while Kasese District had high seropreva-
lence reflecting a situation with frequent reports of FMD 
outbreaks and vaccinations.
Thirty-five of the Kasese 2007 samples (18%) were posi-
tive only in the NSP test (Table 1), and half of these samples 
came from a herd with higher titers of antibodies against the 
SAT serotypes than against serotype O (K1),14 confirming 
the results from Ks12 sampled in 2006, while the remaining 
18 samples were dispersed among 10 of the 16 sampled 
herds.14
The NSP test, like other commercially available test kits 
for antibodies against the NSPs of FMDV, have important 
applications in differentiating infected from vaccinated ani-
mals,19 but this usage may be complicated by nonpurified 
FMDV vaccines inducing antibodies against the NSPs.10,14,20 
Such vaccines including FMDV serotypes O, SAT1, and 
SAT2 were applied in the investigated regions in 2005, 2006, 
and 2007, and it is thus not possible to definitively conclude 
if the antibodies detected in the NSP test were elicited by 
vaccination and/or infection.
The differences between the performances of the NSP test 
and the SP-O test in small ruminants followed the results in 
cattle, but were not statistically significant due to low num-
bers of positives. These variations were most likely results of 
the presence of antibodies against FMDV serotype O after 
the outbreak of FMDV serotype O during 2006.4 The much 
higher seroprevalence in sheep and goats in the 2006 PO 
sampling than in the 2007 RS, combined with the higher 
seroprevalence in cattle in 2007, may indicate faster waning 
of antibodies in these species than in cattle as previously 
Table 3. Serological analysis for Foot-and-mouth disease virus (FMDV) of a cattle herd (Ks12) in the Kasese District of Uganda with 
high seroprevalence in the Ceditest® FMDV-NS enzyme-linked immunosorbent assay (ELISA) and low seroprevalence in the Ceditest® 
FMDV type O ELISA.*
Optical density percentage in 
screening for antibodies against: SPBE antibody titer for FMDV serotype
Sample ID FMDV-NS FMDV type O O SAT1 SAT2 SAT3
53 30 69 ND − 40  20
55 6 2 − ND ND ND
56 35 83 − − 20  10
57 29 88 − 10 10 ND
58 7 83 − − 40  10
62 7 96 − ND ND ND
63 43 56 − − 10  40
64 41 90 − − 20  20
67 20 107 − − 20 −
69 27 104 − 640 20  10
70 11 71 − INC 40  10
71 35 99 − ND ND ND
72 52 97 − 20 10  20
73 27 99 − − ND ND
74 47 83 − ND ND ND
75 96 23 − − 10  80
76 51 107 − − 20 ND
78 18 94 − − 20 INC
79 40 71 − INC 80 160
82 5 82 − − 40 160
Total 17/20 (85) 2/20 (10) 0/19 (0) 3/16 (19) 15/15 (100) 11/13 (85)
*SPBE = solid phase blocking enzyme-linked immunosorbent assay; SAT = South African Territories. Positive samples (optical density percentage < 50%) 
are in bold type. The highest titer in each sample is in bold italic type. – = negative when screened in a dilution of 1:10; ND = not done due to depletion 
of serum; INC = inconclusive, which means positive when screened in a dilution of 1:10, but negative in a dilution of 1:10 (just above the cut-off ), when 
titrated from 1:10 to 1:1280. Total indicates number of positive/number of tested, with percentages in parentheses.
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reported,11,12 but could also be a consequence of the common 
practice of not vaccinating small ruminants.
The results of the SPBE-O test matched those of the SP-O 
test in cattle sampled in 2006 (PO sampling), while the first test 
was more sensitive in cattle sampled in 2007 RS and in buffalo 
that tested positive for antibodies against SAT serotypes. In 
small ruminants, these 2 tests were also more in agreement in 
the 2006 PO sampling than in the 2007 RS. The results from 
buffalo clearly demonstrate that the SPBE-O when used in dilu-
tion of 1:5 is less specific with regard to identifying serotype 
than the SP-O test. The data, taken together with reported pre-
dominance of antibodies against SAT serotypes,2,3 indicate that 
the SP-O test may not be very efficient for identification of anti-
bodies against the SAT serotypes of FMDV, and thus cannot be 
recommended as a pan-FMDV antibody test.
Like other commercially available test kits for antibodies 
against the NSPs of FMDV, the NSP test has important appli-
cations in differentiating infected from vaccinated animals,21 
but this usage may be complicated by detection of antibodies 
against FMDV NSPs elicited by nonpurified FMDV vac-
cines,10,21 which are applied in some sub-Saharan African 
countries including Uganda. This was also the case in the 
samplings in the current study, where nonpurified trivalent 
vaccines had been used in the area in vaccination campaigns 
in cattle in 2005, 2006, and 2007. Thus, in the presented 
analysis of cattle samples from 2006 and 2007, it is impos-
sible to conclude whether the identified antibodies were 
induced by vaccination and/or infection. However, the NSP 
test can still be applied for mass screening to identify ani-
mals with antibodies against FMDV whether these are 
vaccine-derived or elicited by infection.20
In conclusion, though the SP-O test is of low specificity 
toward antibodies against the Eurasian FMDV serotypes9 
and it has been speculated that this test could be used as a 
pan-FMDV antibody test, this usage cannot be recommended 
in populations where the SAT serotypes of FMDV are preva-
lent, as exemplified by the SAT-infected buffalo and the 
cattle herd exposed to 1 or more of the SAT serotypes, only. 
The SP-O test can be used in combination with the NSP test 
when investigating FMD outbreaks caused by serotype O; 
however, it will not be possible to use the NSP test to differ-
entiate between vaccinated and infected animals as long as 
nonpurified vaccines are applied in the region.
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